This article is for: People researching MEDVi for weight loss who want honest pricing, results, and comparisons before signing up.

What Is MEDVi?

MEDVi is a direct-to-consumer telehealth platform specializing in weight loss through GLP-1 receptor agonist medications. The company provides compounded versions of semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (found in Mounjaro and Zepbound) through online consultations with board-certified physicians.

Unlike traditional telehealth services that prescribe brand-name medications, MEDVi works with compounding pharmacies to create custom formulations of these GLP-1 drugs. This approach significantly reduces costs, making medications that typically cost over $1,000 per month available for under $200.

The service launched during the widespread GLP-1 shortage that began in 2022. FDA regulations allow compounding pharmacies to produce versions of drugs experiencing supply shortages. Brand-name manufacturers have largely resolved these shortages, but compounding telehealth companies continue operating under ongoing legal and regulatory scrutiny.

How MEDVi Works

The MEDVi process follows a standard telehealth model designed for convenience and accessibility:

Step 1: Online Health Assessment (5-10 minutes)

Patients complete a comprehensive digital intake form covering medical history, current medications, weight loss goals, and eligibility criteria. The questionnaire screens for contraindications like personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Step 2: Physician Review and Consultation

A licensed, board-certified U.S. physician reviews the submitted information. MEDVi claims most reviews occur within 24-48 hours. If approved, the physician creates a personalized treatment plan including medication type (semaglutide or tirzepatide), dosage, and titration schedule.

According to user reports on Reddit, some consultations are asynchronous (messaging only), while others may include brief video calls depending on medical complexity and state regulations.

Step 3: Prescription and Compounding

Once approved, the prescription is sent to MEDVi’s partner compounding pharmacy. The pharmacy prepares the medication according to the prescribed dosage and ships directly to the patient’s address.

Step 4: Medication Delivery (2-7 days)

MEDVi ships medications with ice packs to maintain proper storage temperatures during transit. Injectable formulations arrive with syringes, alcohol wipes, and detailed administration instructions. Tablet formulations (where available) come in marked dosing packages.

Step 5: Ongoing Support and Adjustments

Patients receive access to 24/7 messaging with medical providers for questions, dosage adjustments, or side effect management. Monthly refills are automatically processed unless patients cancel their subscription.

MEDVi Pricing and Costs

MEDVi advertises starting prices around $179 per month, which makes it one of the cheaper compounded GLP-1 options. Actual costs vary based on medication type, dosage, and format.

What’s Included

• Medical consultation and physician review
• Prescribed GLP-1 medication (one month supply)
• Shipping and handling
• Syringes and supplies (for injectable versions)
• 24/7 provider messaging access
• Metabolic and nutrition reports (according to marketing materials)

How MEDVi Pricing Compares

Hidden Costs to Consider

• No insurance accepted: MEDVi is cash-only, meaning no insurance reimbursement
• HSA/FSA eligibility: Can be used but requires documentation
• Commitment periods: Some Reddit users report pressure to commit to multi-month plans
• Cancellation complexity: Multiple reports of difficulty obtaining refunds after cancellation

Is MEDVi Legit? Safety and Regulatory Status

This question has no simple yes-or-no answer. MEDVi operates legally under current FDA compounding regulations. But “legal” and “safe as brand-name medications” are two different things.

The Compounding Distinction

Compounded medications are not FDA-approved. This is not unique to MEDVi but applies to all compounded GLP-1 providers. The FDA explicitly states that compounded drugs “do not undergo FDA’s review for safety, effectiveness, and quality before they are marketed.”

According to FDA guidance, compounded drugs should only be used when: – An FDA-approved drug cannot meet a patient’s medical needs, or – The FDA-approved drug is not commercially available due to shortage

With Wegovy and Zepbound now widely available, the justification for compounded GLP-1s has become less clear, leading to ongoing regulatory scrutiny.

FDA Safety Concerns Specific to Compounded GLP-1s

The FDA has documented several concerning issues with compounded semaglutide (see our best providers list) and tirzepatide across the industry:

1. Improper Storage During Shipping

Injectable GLP-1 medications require refrigeration. The FDA has received complaints about compounded products “arriving warm or with inadequate ice packs.” The agency warns patients not to use any injectable GLP-1 that arrives improperly stored, as temperature exposure compromises drug quality and effectiveness.

2. Dosing Errors Leading to Hospitalization

As of July 31, 2025, the FDA received: – 605 reports of adverse events associated with compounded semaglutide – 545 reports of adverse events associated with compounded tirzepatide

Some adverse events required hospitalization due to dosing errors from patients measuring incorrect doses or physicians miscalculating titration schedules. Common symptoms included severe nausea, vomiting, diarrhea, abdominal pain, constipation, and dehydration.

3. Fraudulent Products and Mislabeling

The FDA identified fraudulent compounded semaglutide and tirzepatide with false pharmacy information on labels. In some cases, the compounding pharmacies listed don’t exist; in others, legitimate pharmacies’ names were used without authorization.

4. Use of Unauthorized Salt Forms

Some compounders use semaglutide sodium or semaglutide acetate instead of the base form used in FDA-approved drugs. The FDA states it “does not have information on whether these salts have the same chemical and pharmacologic properties” and is “not aware of any lawful basis for their use in compounding.”

What Makes a Compounding Pharmacy Trustworthy?

Not all compounding pharmacies operate at the same quality standards. Reputable operations should: – Be licensed in their state and registered with the FDA – Operate as a 503B outsourcing facility (higher regulatory standard) – Source ingredients from FDA-inspected manufacturers – Conduct sterility and potency testing – Maintain proper cold chain logistics – Provide clear dosing instructions and measuring tools

MEDVi does not publicly disclose which compounding pharmacy or pharmacies it partners with, making it difficult for patients to independently verify quality standards.

Real Customer Reviews and Experiences

To understand MEDVi’s actual performance, we examined verified customer reviews from Trustpilot and detailed user experiences shared on Reddit.

Trustpilot Rating: 4.5 out of 5 (Excellent)

MEDVi has a 4.5 out of 5 rating on Trustpilot based on verified customer reviews. Trustpilot labels this “Excellent.” Positive themes from verified reviews include:

• Affordability: Customers consistently mention cost savings versus brand-name options
• Accessibility: Straightforward online process without insurance requirements
• Physician quality: Many reviewers mention helpful, responsive doctors
• Effectiveness: Users report weight loss of 15-30+ pounds
• Fast shipping: Medications typically arrive within 2-5 days

Reddit Experiences: A More Complex Picture

Reddit’s r/tirzepatidecompound community reveals more nuanced experiences with MEDVi, including both success stories and serious complaints.

Positive Experiences:

One user posted a “10-month review” reporting successful weight loss, responsive customer service, and no major issues. They defended MEDVi against critics, noting that “it doesn’t make them a scam if they have 100k+ customers and a percentage have bad experiences.”

Common Complaints:

1. Refund Policy Changes: Multiple users report that MEDVi advertised a money-back guarantee if no weight loss occurred after 3 months, then changed the policy to 5 months after customers requested refunds. One user stated MEDVi refused a refund because they had “fluctuated by 1lb,” claiming any weight change disqualified them.

2. Billing Issues: Several reports of unauthorized refills being charged. One user titled their post “[WARNING] My experience with MEDVi – bait-and-switch prescription + shifting refund amounts.”

3. Customer Service Difficulties: Multiple users report contacting customer service “approximately 50 times between emails and phone calls” with poor resolution. Some customers filed complaints with the Better Business Bureau, Consumer Affairs, and FTC.

4. Product Quality Concerns: A small number of users questioned medication potency, though these are difficult to verify without independent testing.

Quote from a detailed negative review: > “All the reviews regarding not refunding after canceling your subscription are true. Company acts very entitled and refuses to acknowledge their mistakes. Customer service is poor. Read reviews on Consumer Affairs and Google. The disappointment is real.”

Balanced Assessment

MEDVi successfully serves many customers, as the Trustpilot rating shows. But Reddit complaints reveal patterns around refund policies, billing practices, and customer service that potential customers should know about. The gap between positive Trustpilot reviews and critical Reddit posts suggests experiences vary significantly.

MEDVi Pros and Cons

Pros

• Affordable pricing: $179/month versus $1,000+ for brand-name options
• No insurance required: Accessible to those without coverage or high deductibles
• Board-certified physicians: Licensed U.S. doctors oversee prescriptions
• Fast delivery: 2-5 day shipping with most orders
• 24/7 provider messaging: Medical support available for questions
• HSA/FSA eligible: Can use pre-tax healthcare dollars
• Includes support materials: Metabolic reports and meal planning resources
• Medication options: Both semaglutide and tirzepatide available

Cons

• Not FDA-approved: Compounded formulations lack rigorous FDA safety review
• Safety concerns: FDA has documented issues with compounded GLP-1s industry-wide
• Pharmacy transparency: MEDVi doesn’t publicly disclose compounding partners
• Customer service complaints: Multiple Reddit reports of poor support and refund issues
• No insurance reimbursement: Entirely out-of-pocket with no claims filing
• Unclear refund policy: Customers report changing guarantee terms
• Limited clinical oversight: Mostly asynchronous care vs. traditional doctor visits
• Storage risks: Potential temperature control issues during shipping

How MEDVi Compares to Alternatives

MEDVi vs. Ro

Ro offers both compounded and brand-name GLP-1 medications, with Wegovy starting at $199/month for the first two months (promotional pricing through March 2026), then $349/month.

• Price winner: MEDVi ($179 vs. $199-$349)
• FDA approval: Ro offers FDA-approved Wegovy; MEDVi only compounded
• Transparency: Ro clearly distinguishes brand vs. compounded options
• Best for: Those wanting FDA-approved medications should choose Ro; budget-focused individuals may prefer MEDVi

MEDVi vs. Henry Meds

Henry Meds specializes in compounded GLP-1s with semaglutide starting at $197-$297/month depending on dosage.

• Price winner: MEDVi (slightly cheaper starting price)
• Medication options: Both offer compounded semaglutide and tirzepatide
• Reputation: Henry Meds has fewer Reddit complaints about billing/refunds
• Best for: Similar target market; choice may come down to customer service reputation

MEDVi vs. Hims & Hers

Hims & Hers recently launched aggressive pricing for compounded GLP-1s, with oral semaglutide starting at $49/month (first month) then $99/month for 5-month plans. Injectables start at $199/month.

• Price winner: Hims & Hers (especially for oral formulations)
• Format options: Hims & Hers offers more oral options; MEDVi focuses on injectables
• Brand recognition: Hims & Hers is a publicly-traded company with more established presence
• Best for: Those interested in oral formulations should explore Hims & Hers

MEDVi vs. Brand-Name (Wegovy/Zepbound)

Brand-name medications cost $1,000-$1,400/month without insurance but are FDA-approved with extensive clinical trial data.

• Price winner: MEDVi (6-8x cheaper)
• Safety profile: Brand-name medications have comprehensive FDA review
• Insurance coverage: Brand-name may be covered; compounded never is
• Clinical data: Brand-name has extensive trial data; compounded does not
• Best for: Those with insurance coverage should pursue brand-name; those paying cash may consider compounded alternatives while understanding trade-offs

Does MEDVi Actually Work? Expected Results

The medications MEDVi provides (semaglutide and tirzepatide) are based on compounds with strong clinical evidence for weight loss when produced as FDA-approved drugs.

Clinical Trial Data (Brand-Name Versions)

Semaglutide (Wegovy): – Average weight loss: 15-17% of body weight over 68 weeks – Clinical trial participants lost approximately 34 pounds on average – Source: STEP trial program published in New England Journal of Medicine

Tirzepatide (Zepbound): – Average weight loss: 15-21% of body weight (dose-dependent) – Clinical trial participants lost up to 52 pounds on average at highest doses – Source: SURMOUNT trial program published in JAMA

Real-World Results from MEDVi Users

Based on Trustpilot and Reddit reviews, MEDVi customers report: – Noticeable appetite suppression within 1-2 weeks – Initial weight loss of 5-10 pounds in the first month – Long-term weight loss of 15-30+ pounds over 3-6 months – Plateau periods requiring dosage adjustments

Important Caveats

The effectiveness of compounded versions depends on: 1. Accurate compounding: Medications must contain the correct active ingredient at proper potency 2. Proper storage: Temperature exposure during shipping can degrade effectiveness 3. Correct dosing: Users must accurately measure and administer doses 4. Individual response: Results vary based on genetics, diet, exercise, and adherence

While many users report successful weight loss with MEDVi, the lack of FDA oversight means potency and consistency cannot be independently verified as they are with brand-name medications.

Side Effects and Safety Considerations

GLP-1 medications produce predictable side effects regardless of whether they’re brand-name or compounded. However, compounded versions carry additional risks.

Common GLP-1 Side Effects

• Gastrointestinal issues: Nausea, vomiting, diarrhea, constipation (60-70% of users)
• Decreased appetite: Intentional effect but may become excessive
• Fatigue and headaches: Especially during titration phase
• Injection site reactions: Redness, swelling, or itching

These side effects typically diminish as the body adjusts to the medication, usually within 4-8 weeks.

Serious Risks (Rare)

• Pancreatitis: Inflammation of the pancreas
• Gallbladder problems: Including gallstones
• Thyroid tumors: Black box warning for medullary thyroid carcinoma risk
• Hypoglycemia: Especially in patients taking diabetes medications
• Kidney problems: From severe dehydration due to gastrointestinal side effects

Compounding-Specific Concerns

In addition to standard GLP-1 risks, compounded versions carry: – Potency variability: May be over-potent (increasing side effects) or under-potent (reducing effectiveness) – Contamination risk: Lower quality control compared to FDA-approved facilities – Storage degradation: Temperature exposure during shipping compromises drug stability – Dosing errors: Self-measuring from vials increases risk of incorrect dosing

Who Should Avoid MEDVi

• Personal or family history of medullary thyroid carcinoma or MEN2 syndrome
• Pregnant or breastfeeding individuals
• History of pancreatitis
• Severe gastrointestinal disease
• Those with insurance coverage for brand-name alternatives
• Anyone uncomfortable with compounded medication risks

Frequently Asked Questions

Is MEDVi FDA approved?

No. MEDVi provides compounded medications that are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. This applies to all compounding telehealth providers, not just MEDVi.

How much does MEDVi cost per month?

MEDVi starts at $179 per month, though exact pricing varies by medication type (semaglutide vs. tirzepatide), dosage, and format (injection vs. tablet where available).

Does MEDVi accept insurance?

No. MEDVi is a cash-pay program that does not accept insurance or file claims. However, you may be able to use HSA/FSA funds for payment.

Is MEDVi the same as Wegovy or Ozempic?

No. MEDVi provides compounded semaglutide (see our best providers list), which contains the same active ingredient as Wegovy and Ozempic but is not manufactured by Novo Nordisk and is not FDA-approved. The compounded version may have different inactive ingredients, potency levels, and quality standards.

How long does MEDVi shipping take?

Most customers report receiving medications within 2-5 days. MEDVi ships with ice packs to maintain refrigeration during transit.

Can I cancel MEDVi at any time?

According to company policy, yes. However, multiple Reddit users report difficulty obtaining refunds after cancellation, particularly regarding MEDVi’s money-back guarantee. Read cancellation terms carefully before committing.

What if MEDVi doesn’t work for me?

MEDVi has advertised a money-back guarantee, though specific terms appear unclear based on customer complaints. Multiple users report the guarantee period changed from 3 to 5 months, and that any weight fluctuation (even 1 pound) disqualified them from refunds. Clarify refund terms directly with MEDVi before starting.

Are there alternatives to MEDVi?

Yes. Alternatives include: – Other compounding providers: Henry Meds, Direct Meds, Fella Health (men only), Hims & Hers, Ro (compounded options) – Brand-name with insurance: Wegovy, Zepbound through traditional prescriptions – Lower-cost brands: Ro offers promotional Wegovy pricing – Non-GLP-1 options: Contrave, phentermine, or lifestyle-based programs

Is compounded semaglutide safe?

Compounded semaglutide carries the same inherent medication risks as brand-name semaglutide, plus additional risks from: – Lack of FDA quality oversight – Potential potency variability – Storage and shipping concerns – Increased dosing error risk

The FDA has documented over 600 adverse events associated with compounded semaglutide as of July 2025. While many customers use compounded versions without serious issues, the safety profile is less established than FDA-approved alternatives.

How do I contact MEDVi customer service?

MEDVi provides 24/7 messaging through their patient portal. Based on Reddit reports, some customers experienced difficulty reaching responsive support. The company does not prominently list phone numbers on their website.

Can I use MEDVi with HSA or FSA funds?

Yes. Since GLP-1 medications are prescription drugs for a medical condition (obesity), they generally qualify for HSA/FSA reimbursement. You’ll need to save receipts and documentation for your FSA/HSA administrator.

Final Verdict: Is MEDVi Right for You?

MEDVi operates in a complicated intersection of affordability, accessibility, and regulatory ambiguity. The service successfully provides weight loss medications to thousands of customers at a fraction of brand-name costs, but comes with trade-offs that prospective users must carefully weigh.

MEDVi Makes Sense For:

• Budget-conscious individuals who can’t afford $1,000+ brand-name prices and lack insurance coverage
• People comfortable with compounding trade-offs who understand they’re choosing cost savings over FDA approval
• Those seeking accessible weight loss support without navigating insurance pre-authorizations
• Patients with BMI ≥30 or ≥27 with weight-related health conditions

Consider Alternatives If:

• You have insurance coverage that may pay for Wegovy or Zepbound (pursue brand-name first)
• You prioritize FDA oversight and comprehensive quality assurance over cost savings
• You’re risk-averse regarding medication safety and prefer established approval processes
• You need strong customer service and transparent refund policies

Action Steps for Interested Readers

If you’re considering MEDVi:

1. Research current FDA guidance on compounded GLP-1s at FDA.gov
2. Check brand-name pricing through Ro, NovoCare, or your insurance to compare true costs
3. Read current Reddit discussions in r/tirzepatidecompound for recent customer experiences
4. Clarify refund policies in writing before committing to treatment
5. Consult your primary care physician about whether compounded GLP-1s are appropriate for your situation
6. Inspect medication upon arrival for proper refrigeration and clear labeling
7. Report any concerns to the FDA through MedWatch if you experience problems

The compounded GLP-1 market remains in flux, with ongoing FDA enforcement actions and evolving regulations. MEDVi is one option in a field of imperfect choices: expensive FDA-approved medications or affordable compounded alternatives with less oversight.

For many cash-paying patients, compounded options like MEDVi may be the only financially accessible path to GLP-1 therapy. For others with insurance or lower risk tolerance, brand-name medications offer greater assurance. There’s no universally “right” answer, only informed decisions based on individual circumstances, priorities, and risk tolerance.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult with a qualified healthcare provider before starting any weight loss medication. Individual results and experiences may vary.

Last Updated: February 25, 2026